Markets:

Overview

News

Currencies

International

Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

9.780 +0.680 (+7.47%)

Streaming Delayed Price Updated: 11:48 AM EDT, Jun 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karyopharm Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts ↗

May 26, 2026

Karyopharm Therapeutics (NASDAQ:KPTI) executives used an H.C. Wainwright BioConnect Conference appearance to highlight upcoming clinical and regulatory milestones for selinexor, the company’s oral...

Via MarketBeat

Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus ↗

May 26, 2026

Karyopharm Therapeutics (NASDAQ:KPTI) executives said the company expects to provide a fuller presentation of its Phase 3 SENTRY trial data for selinexor in myelofibrosis at the upcoming ASCO...

Via MarketBeat

Karyopharm (KPTI) Q1 2026 Earnings Transcript ↗

May 14, 2026

Karyopharm (KPTI) Q1 2026 Earnings Transcript

Via The Motley Fool

Karyopharm Therapeutics Inc (NASDAQ:KPTI) Posts Q1 Beat and Highlights ASCO Presentation, Shares Surge 7% ↗

May 14, 2026

Via Chartmill

Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market ↗

February 12, 2026

Via Chartmill

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Karyopharm Therapeutics Earnings Preview ↗

October 31, 2025

Via Benzinga

Karyopharm Therapeutics Q1 Earnings Call Highlights ↗

May 14, 2026

Karyopharm Therapeutics (NASDAQ:KPTI) said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofibrosis and an expected midyear readout in...

Via MarketBeat

Topics Earnings

Karyopharm (KPTI) Q2 2025 Earnings Transcript ↗

May 04, 2026

Karyopharm (KPTI) Q2 2025 Earnings Transcript

Via The Motley Fool

Karyopharm (KPTI) Q1 2025 Earnings Transcript ↗

May 04, 2026

Karyopharm (KPTI) Q1 2025 Earnings Transcript

Via The Motley Fool

Earnings Outlook For Karyopharm Therapeutics ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Registration Momentum Builds Across the Oncology Pipeline

February 17, 2026

Issued on behalf of Oncolytics Biotech Inc.

From USA News Group

Via GlobeNewswire

Karyopharm (KPTI) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

Karyopharm (KPTI) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Derivatives Earnings

Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q3 2025 Revenue Beat and Earnings Miss ↗

November 03, 2025

Karyopharm (KPTI) Q3 2025 results show a revenue beat but an earnings miss. The stock rose pre-market as investors focus on XPOVIO sales growth and key Phase 3 data due in 2026.

Via Chartmill

Topics Earnings

This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

October 13, 2025

Via Benzinga

Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026 ↗

October 08, 2025

Karyopharm secures $100 million financing, extends cash runway into 2026, projects $42 million–$44 million Q3 revenue, and advances Phase 3 selinexor trial.

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

October 08, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session. ↗

August 15, 2025

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 11, 2025

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 11, 2025

Via Benzinga

These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results ↗

May 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 23, 2025

Via Benzinga

Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

April 08, 2025

Via Benzinga

What's going on in today's session ↗

February 26, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.